N 
13,270
-5.82%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩18.95bn
FY2019FY2025
Net income
−₩21.97bn
FY2019FY2025
Free cash flow
−₩14.53bn
FY2019FY2025
Shareholders' equity
₩13.88bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | ₩18.95bn | ₩25.27bn | ₩13.74bn | ₩9.75bn | ₩7.35bn | ₩4.07bn | ₩7.21bn |
| Gross profit | ₩3.46bn | ₩4.14bn | ₩1.22bn | ₩2.05bn | ₩1.84bn | ₩247.9m | ₩1.45bn |
| Research and development | ₩5.42bn | ₩6.62bn | ₩5.26bn | ₩1.92bn | ₩931.7m | ₩3.82bn | — |
| Operating income | — | −₩19.02bn | −₩16.69bn | −₩7.80bn | — | −₩8.15bn | −₩5.29bn |
| Net income | −₩21.97bn | −₩16.75bn | −₩17.65bn | −₩8.20bn | −₩6.59bn | −₩8.27bn | −₩2.99bn |
| Diluted earnings per share | -1,061.18 | -1,580.42 | -1,676.23 | -793.44 | -669.10 | -839.23 | -303.67 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | ₩91.38bn | ₩95.23bn | ₩95.72bn | ₩43.83bn | ₩24.33bn | ₩12.06bn | ₩15.09bn |
| Cash and short-term investments | — | — | — | ₩28.52bn | ₩15.84bn | ₩3.61bn | ₩3.19bn |
| Total liabilities | ₩77.48bn | ₩84.36bn | ₩71.66bn | ₩4.10bn | ₩8.77bn | ₩9.87bn | ₩4.79bn |
| Debt | ₩8.10bn | ₩24.58bn | ₩18.30bn | ₩2.07bn | ₩3.27bn | ₩9.11bn | ₩3.63bn |
| Shareholders' equity | ₩13.88bn | ₩10.87bn | ₩24.06bn | ₩39.73bn | ₩15.56bn | ₩2.19bn | ₩10.30bn |
| Shares outstanding | 21m | 11m | 11m | 10m | 10m | 10m | 10m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | −₩11.36bn | −₩21.93bn | −₩12.43bn | −₩8.00bn | −₩1.06bn | −₩4.02bn | −₩7.12bn |
| Capital spending | −₩3.17bn | −₩13.79bn | −₩30.60bn | −₩3.32bn | −₩292.5m | −₩299.0m | −₩1.34bn |
| Free cash flow | −₩14.53bn | −₩35.72bn | −₩43.04bn | −₩11.32bn | −₩1.35bn | −₩4.32bn | −₩8.46bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2.82bn | ₩2.99bn | ₩7.87bn | ₩4.47bn | ₩3.44bn | ₩3.17bn | ₩8.05bn | ₩6.23bn |
| Gross profit | ₩596.7m | ₩675.1m | ₩1.50bn | ₩746.1m | ₩1.35bn | ₩578.9m | ₩772.0m | ₩914.3m |
| Operating income | −₩5.27bn | −₩4.31bn | — | −₩3.10bn | −₩4.28bn | −₩6.08bn | −₩2.82bn | −₩5.69bn |
| Net income | −₩4.50bn | −₩25.62bn | −₩5.74bn | −₩4.28bn | −₩4.62bn | −₩7.31bn | −₩4.03bn | −₩6.79bn |
| Diluted earnings per share | -217.36 | -1,237.22 | -277.39 | -225.19 | -243.47 | -645.02 | -380.13 | -644.27 |
| Cash from operations | −₩2.91bn | −₩12.28bn | ₩218.0m | −₩3.59bn | ₩3.09bn | −₩11.07bn | −₩21.93bn | −₩20.03bn |
| Capital spending | −₩4.47bn | −₩536.0m | −₩147.0m | −₩446.0m | −₩1.90bn | −₩679.0m | −₩13.79bn | −₩7.91bn |
| Free cash flow | −₩7.37bn | −₩12.81bn | ₩71.0m | −₩4.04bn | ₩1.19bn | −₩11.75bn | −₩35.72bn | −₩27.94bn |
| Total assets | ₩92.06bn | ₩82.75bn | ₩91.38bn | ₩92.50bn | ₩94.62bn | ₩94.60bn | ₩95.23bn | ₩83.41bn |
| Cash and short-term investments | — | — | — | — | — | ₩14.51bn | ₩20.03bn | ₩14.31bn |
| Debt | ₩9.60bn | ₩7.72bn | ₩8.10bn | ₩28.83bn | ₩28.98bn | ₩25.91bn | ₩26.28bn | ₩22.89bn |
| Shareholders' equity | ₩36.38bn | ₩40.36bn | ₩13.88bn | ₩14.16bn | ₩18.32bn | ₩23.01bn | ₩10.87bn | ₩11.95bn |
Financial ratios
Data as of 30 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 18.3% | 16.4% | 8.9% | 21.0% | 25.0% | — |
| Operating margin | — | -75.2% | -121.5% | -79.9% | — | — |
| Net margin | -115.9% | -66.3% | -128.5% | -84.1% | -89.7% | — |
| Return on equity | -158.3% | -154.1% | -73.4% | -20.6% | -42.4% | — |
| Return on assets | -24.0% | -17.6% | -18.4% | -18.7% | -27.1% | — |
| Revenue growth | -25.0% | 83.9% | 40.9% | 32.7% | — | — |
| Earnings growth | 31.1% | -5.1% | 115.3% | 24.4% | — | — |
| Current ratio | 0.55x | 0.73x | 1.10x | 9.78x | 2.60x | 0.95x |
| Debt to equity | 0.58x | 2.26x | 0.76x | 0.05x | 0.19x | 1.37x |
| Equity ratio | 15.2% | 11.4% | 25.1% | 90.6% | 64.0% | 18.1% |
| Interest coverage | — | -3.86x | -8.14x | -26.71x | — | — |
| R&D as a share of sales | 28.6% | 26.2% | 38.3% | 19.7% | 12.7% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 24.8% | 36.1% | — |
| Net income | 38.9% | 21.6% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 17.2% | 16.1% | 16.4% | — |
| Net margin | -87.6% | -95.4% | -100.4% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | -13.8 | -8.1 | -9.8 | -7.0 |
| Price to sales | 16.0 | 5.4 | 12.7 | 5.9 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.